Anticoagulation & Antiinflammatory Management for Endoscopy



Anticoagulation & Antiinflammatory Management for Endoscopy





(Gastrointest Endosc 2005;61:189-194)














WARFARIN THERAPY


HIGH-RISK PATIENTS:
Afib associated with valvular disease
Mechanical valve in the mitral position
Mechanical valve and prior thromboembolic event


LOW-RISK PATIENTS:
DVT
Uncomplicated or paroxysmal Afib
Bioprosthetic valve
Mechanical valve in aortic position


HIGH-RISK PROCEDURES:
Polypectomy
Biliary Sphincterotomy
Pneumatic or Bougie dilation
PEG
ERCP/EUS with FNA
Laser ablation and coagulation
Treatment of varices


Stop warfarin 3-5 days before;
Consider heparin while INR below therapeutic


Stop warfarin 3-5 days before
Restart warfarin after procedure


LOW RISK PROCEDURES:
Diagnostic: EGD/Cscope/Flex Sig ± Biopsy
ERCP without Sphincterotomy
Biliary/Pancreatic stent without endoscopic sphincterotomy
EUS without FNA
Enteroscopy


No change in anticoagulation; Elective procedures should be delayed while INR is supratherapeutic

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Aug 24, 2016 | Posted by in GASTROENTEROLOGY | Comments Off on Anticoagulation & Antiinflammatory Management for Endoscopy

Full access? Get Clinical Tree

Get Clinical Tree app for offline access